Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: A report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group - Université Claude Bernard Lyon 1 Access content directly
Journal Articles Journal of Clinical Oncology Year : 2007

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: A report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group

R.M. Brohet
  • Function : Author
D.E. Goldgar
  • Function : Author
D.F. Easton
  • Function : Author
A.C. Antoniou
  • Function : Author
N. Andrieu
  • Function : Author
J. Chang-Claude
  • Function : Author
S. Peock
  • Function : Author
R.A. Eeles
  • Function : Author
M. Cook
  • Function : Author
C. Chu
  • Function : Author
  • PersonId : 846855
C. Nogues
  • Function : Author
P. Berthet
  • Function : Author
H. Meijers-Heijboer
  • Function : Author
A.M. Gerdes
  • Function : Author
H. Olsson
  • Function : Author
T. Caldes
  • Function : Author
F.E. Van Leeuwen
  • Function : Author
M.A. Rookus
  • Function : Author
No file

Dates and versions

hal-02311205 , version 1 (10-10-2019)

Identifiers

  • HAL Id : hal-02311205 , version 1

Cite

R.M. Brohet, D.E. Goldgar, D.F. Easton, A.C. Antoniou, N. Andrieu, et al.. Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: A report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group. Journal of Clinical Oncology, 2007, 25 (25), pp.3831-3836. ⟨hal-02311205⟩
8 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More